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Available online 16 May 2016The presence of metabolic syndrome (MetS) increases the risk of developing type 2 diabetes and cardiovascular
disease. Targeted interventions to reduce MetS for high risk populations are crucial for the prevention of these
chronic diseases. This study evaluated the effectiveness of a 6-month home-based physical activity and diet in-
tervention for rural adults with, or at risk of MetS. The randomised controlled trial was conducted in Albany
and surrounding towns, Western Australia, 2014–2015. Participants were screened for MetS using the Interna-
tional Diabetes Federation criteria, and eligible participants were randomly assigned to the intervention (n =
201) or control (n = 200) group. The intervention group received printed and online programme materials
andmotivational support, and the control groupwaswaitlisted to receive the programmeafter post-test data col-
lection. Anthropometry, lipid proﬁles, glycaemic status, and blood pressure were measured at baseline and 6-
months post-test. In total, 312 (77.8%) participants completed post-test data collection and were included in
the anthropometric analysis, and 274 (68.3%) participants were included in the blood sample analysis. After con-
trolling for confounders, the intervention group signiﬁcantly improved their triglyceride (−0.10 mM, p =
0.002), total cholesterol (−0.09mM, p= 0.02), and non-HDL cholesterol (−0.08mM, p= 0.02) concentrations
compared to the control group.Waist circumference (−2.11 cm, p=0.03), waist-to-hip ratio (−0.01, p=0.04),
weight (−0.70 kg, p=0.01), and bodymass index (−0.20 kg/m2, p b 0.001)were also improved. These ﬁndings
suggest that comprehensive home-based prevention programmes that include a combination of dietary and
physical activity interventions are a promising means to prevent the onset of chronic disease in rural adults.
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Obesity and its associated chronic diseases are a growing public
health concernworldwide. Since the 1980's, global overweight and obe-
sity prevalence has increased by 28% in adults and 47% in children,
which equates to an estimated 2.1 billion people (Ng et al., 2014). In
Australia, approximately two-thirds (63%) of the population are over-
weight or obese (Australian Institute of Health and Welfare, 2014)
which is an increase of approximately 9% in the last 17 years
(Australian Bureau of Statistics, 2011). The proportion of adults aged
50+ who are overweight or obese has reached 70%, indicating thation; ATPIII, National Cholesterol
Australian Type 2 Diabetes Risk
estimating equation; HDL, high
n; LDL, low density lipoprotein;
ial.
6845, Australia.
d).
. This is an open access article underprevalence increases with age (Australian Bureau of Statistics, 2013a).
Additionally, the prevalence of overweight/obesity has been rising
more so among middle-aged adults living in harder to reach and often
neglected rural/remote areas of Australia (Australian Bureau of
Statistics, 2011).
The combination of excess weight and older age increases the prev-
alence of metabolic syndrome, which is deﬁned by the presence of
dyslipidaemia, hyperglycaemia, and hypertension (Blaha et al., 2008).
Advancing age is a major contributor to all metabolic syndrome param-
eters (Grundy et al., 2004; Han & Lean, 2006). Prevalence also increases
with bodymass index (BMI) (Han &; Lean, 2006; Kassi et al., 2011), due
to abdominal obesity being common to each of themetabolic syndrome
parameters (Zimmet et al., 2005).
Metabolic syndrome is considered a worldwide epidemic (Alberti et
al., 2009). It is estimated that approximately one fourth of adults world-
wide carry the syndrome (Grundy, 2008). Individuals with metabolic
syndrome are at increased risk of developing type 2 diabetes mellitus
and cardiovascular disease (Blaha et al., 2008; Salas-Salvado et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Australian Institute of Health and Welfare, 2014), the majority of
cases (85%) are type 2 which is a largely preventable disease
(Australian Institute of Health and Welfare, 2014). Australian adults
aged 65–74 years have the highest rate (15%) of diabetes compared to
other age groups, and the 55–74 year age group has the highest rate
of newly diagnosed cases (2.3%) of diabetes in Australia (Australian
Bureau of Statistics, 2013b).
There is a high cardiovascular risk associated with individuals who
have a metabolic syndrome diagnosis (Barazzoni et al., 2013), often
due to the presence or increased risk of type 2 diabetes. For those
with type 2 diabetes the risk of stroke is increased 2- to 4-fold, and
the risk of myocardial infarction is increased 3- to 4-fold (Kaur, 2014).
Diabetes ranks higher as a cause of death in rural and remote areas
than major cities (Australian Institute of Health and Welfare, 2014),
with the main contributor to higher mortality rates being coronary
heart disease (Australian Institute of Health and Welfare, 2014). Other
possible adverse health outcomes of metabolic syndrome include poly-
cystic ovary syndrome, Cushing's syndrome, stress, depression, and
some cancers (Han & Lean, 2006).
Management of chronic diseases and related health issues becomes
difﬁcult once they develop, highlighting the need for an early warn-
ing/screening system to protect those at risk (Sherwin & Jastreboff,
2012). The early identiﬁcation of populations at risk of chronic disease
provides anopportunity for the implementation of preventivemeasures
(Australian Institute of Health andWelfare, 2014). In particular, identi-
fying obese individuals at risk of, or with metabolic syndrome residing
in rural/remote locations is a clinical priority (Barazzoni et al., 2013).
Implementing effective metabolic syndrome management is essen-
tial when considering its documented progression to type 2 diabetes,
cardiovascular disease, and other health issues if left unmanaged
(Camhi et al., 2010). A systematic review of 13 RCTs with 3907 individ-
uals revealed lifestyle interventions to be more effective than pharma-
cological therapies at reversing metabolic syndrome (Dunkley et al.,
2012), and in turn preventing its progression to cardiovascular disease
and type 2 diabetes. It is nowdocumented that all of the clinicalmarkers
of metabolic syndrome can be improved with diet and physical activity
intervention (Bassi et al., 2014); thereforeweight loss via diet and phys-
ical activity modiﬁcation should be the focus of interventions (Mecca et
al., 2012).
Effective lifestyle interventions directed at metabolic syndrome use
a combination of counselling, motivational support, education, goal set-
ting, and tailored feedback (Brauer et al., 2015; Hartmann-Boyce et al.,
2015). A recent systematic review found that the optimal strategies to
address metabolic syndromewere motivational support, internet mon-
itoring, and regular personal feedback (Bassi et al., 2014), achieved via
home-based self-help interventions. Such interventionsmay be particu-
larly suitable for disadvantaged rural communities targeting older
adults with or at risk of metabolic syndrome (Hartmann-Boyce et al.,
2015; McNaughton et al., 2012).
Due to the ageing population and the higher proportion of older adults
outside major cities (Australian Institute of Health and Welfare, 2014),
rural areas will requiremore targeted services for older adults in the con-
text of chronic disease prevention (Janus et al., 2007). Home-based inter-
ventions offer a solution to the barriers experience by rural populations
such as limited access to health services and greater distances to travel
to available services (Australian Institute of Health and Welfare, 2014),
and are suitable for those who have employment commitments because
the programme can be undertaken at any time. The effectiveness of
home-based lifestyle interventions for older adults with metabolic syn-
drome residing in rural/remote Australian regions is under-researched
(McNaughton et al., 2012). The Albany Physical Activity and Nutrition
(APAN) programmeaimed to address this gap by identifying and improv-
ing the lifestyle behaviours of rural adultswith or at risk ofmetabolic syn-
drome. The purpose of the current studywas to evaluate the effectiveness
of the APAN intervention in terms of improvement in metabolicparameters and cardiovascular risk factors for this disadvantaged popula-
tion subgroup. The changes in diet and physical activity behaviours have
been reported separately (Blackford et al., 2016).
2. Methods
2.1. Study design and intervention
The APAN study was a RCT of a 6 month home-based physical activ-
ity and diet intervention, adapted from a 6 month intervention for a
similar target group (Burke et al., 2012). The intervention strategies
and resources included printed and interactive online programme ma-
terials, developed based on the Australian Dietary Guidelines
(National Health and Medical Research Council, 2013) and Australia's
Physical Activity and Sedentary Behaviour Guidelines (Department of
Health, 2014). Participants were encouraged to set goals and self-mon-
itor their progress, and received support from research staff usingmoti-
vational interviewing techniques (Resnicow & McMaster, 2012). All
participants were informed of the study aims and procedures, and pro-
vided written informed consent. Details of the study design and inter-
vention have been described previously (Blackford et al., 2015). The
study protocol was approved by the Curtin University Human Research
Ethics Committee (approval number HR149_2013) and the trial was
registered with the Australian and New Zealand Clinical Trials Registry
(ACTRN12614000512628).
2.2. Participants
Adults residing in Albany and environs in the Great Southern region
ofWestern Australiawere contacted randomly via telephone. Interested
participants were screened for study eligibility initially using the Aus-
tralian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) (Chen et al.,
2010), followed by clinical measures obtained at a local clinic. Partici-
pants (n = 401), aged 50 to 69 years and classiﬁed as either having or
being at risk of metabolic syndrome, were randomly assigned to a
6 month lifestyle intervention (n = 201) or control group (n = 200).
The participants and recruitment procedure have been previously re-
ported in detail (Blackford et al., 2016).
2.3. Deﬁnition of metabolic syndrome
Individuals at an increased cardiovascular risk can be identiﬁed using
clinical deﬁnitions of metabolic syndrome (Blaha et al., 2008). The most
current deﬁnitions are theNational Cholesterol Education ProgramAdult
Treatment Panel III (ATPIII) criteria and the International Diabetes Feder-
ation (IDF) criteria (Kassi et al., 2011). The IDF criteria address the causal
link between central obesity and the other components ofmetabolic syn-
drome by ensuring obesity is an absolute in the screening process
(International Diabetes Federation, 2006), and is therefore considered
most suitable for clinical practice to prevent andmanage obesity-related
health issues (Kassi et al., 2011). The IDF deﬁnition has therefore been
used to deﬁne metabolic syndrome in the present study.
The IDF deﬁnition (Han & Lean, 2006) includes a largewaist circum-
ference as the minimum requirement (waist circumference ≥ 94 cm for
men or ≥80 cm for women [Europids, Sub-Saharan Africans, Eastern
Mediterranean, Middle East]; ≥90 cm for men or ≥80 cm for women
[SouthAsians, Chinese, Japanese]), plus any two of the following param-
eters: raised triglyceride level (≥1.7mM, or treatment for this); reduced
high density lipoprotein (HDL) cholesterol (b1.03 mM in males and
b1.29 mM in females, or treatment for this); raised blood pressure
(systolic ≥ 130 mm Hg or diastolic ≥ 85 mm Hg, or treatment of previ-
ously diagnosed hypertension); raised fasting plasma glucose
(≥5.6 mM). The purpose of applying the IDF criteria in the present
study was to ensure participants with central obesity were recruited
to enable assessment of weightmanagement and the associated clinical
beneﬁts of chronic disease prevention (Han & Lean, 2006).
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met the full IDF criteria stated above. Participantswhomet the above re-
quirement for central obesity and only satisﬁed one (instead of two) of
the latter four additional conditions speciﬁed by IDFwere classiﬁed as at
risk of metabolic syndrome and also included in the present study. The
aim of also targeting these individuals was to assess the effectiveness of
the intervention at preventing the onset of metabolic syndrome and as-
sociated chronic diseases (Kaur, 2014; Hsiung et al., 2014). The full re-
cruitment procedure has been reported previously (Blackford et al.,
2016); however a summary is provided in Fig. 1.
2.4. Outcome measures
The primary outcome measures were changes to blood parameters,
blood pressure, and anthropometry,measured at baseline and post-test.Fig. 1. CONSORT ﬂowdiagram Table 1 summarises baseline characteristics of the intervention a
mean age of 61 years (SD = 5.41). There were no signiﬁcant differences between the groups a
anthropometric measurements. No differences were observed in comparisons of study compleFasting blood samples (N10 h) were taken by a phlebotomist at a local
pathology lab. Fasting plasma glucose, cholesterol and triglyceride con-
centrations were measured, and low density lipoprotein (LDL)-, total-,
HDL-, non-HDL-cholesterol levels were subsequently determined
(Nordestgaard & Varbo, 2014). Remnant cholesterol was also deter-
mined due to the associated increased risk of cardiovascular disease
(Nordestgaard & Varbo, 2014), as it is understood to be a more likely
causal factor than reduced HDL cholesterol (Varbo et al., 2013). Systolic
and diastolic blood pressure were measured by a trained researcher
using an Omron M5-1 electronic sphygmomanometer. The participant
was in a sitting position for 5 min prior to the ﬁrst measurement. Read-
ings were taken from the upper arm 1min apart, with a mean value re-
corded after threemeasurements (Pickering et al., 2005).Waist and hip
circumference were recorded to the nearest 0.5 cm using a plastic mea-
suring tape, and waist-to-hip ratio (waist/hip) was subsequentlynd control groups. The sample consisted of predominantly females (66.5%)with an overall
t baseline in terms of demographic characteristics, blood parameters, blood pressure, and
ters and study dropouts.
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0.01 kg using a Tanita digital scale, and height was recorded to the
nearest 0.1 cm using a stadiometer while the participant was barefoot.
BMI (weight [kg] / height [m]2) was subsequently determined.2.5. Statistical analysis
Descriptive statistics summarised the baseline demographic and
lifestyle characteristics,metabolic syndromeparameters, and anthropo-
metric measurements of the sample. Continuous outcome variables
were compared between and within groups using independent and
paired t tests, with non-parametric Mann–Whitney U tests and
Wilcoxon Signed Rank tests applied to variables with skewed distribu-
tions. Generalised estimating equation (GEE) models with exchange-
able correlation structure were used to analyse repeated measures
over time, while accounting for demographic and other potential con-
founders. Normally distributed continuous variables were assessed
using a normal GEE model with identity link, whereas skewed continu-
ous variables were assessed using a gamma GEE model with log link.3. Results
Fig. 1 presents the CONSORT ﬂow chart, which outlines the study
procedure and sample sizes. The initial recruitment phase occurred
from October 2013 to December 2014, with post-test measurements
completed in August 2015. During the follow-up, 151 (75.1%) interven-
tion and 161 (80.5%) control group participants returned to the clinic for
post-test data collection andwere available for anthropometric analysis,
of which 151 (75.1%) intervention and 159 (79.5%) controls completed
the questionnaire and were available for the analysis of demographic
characteristics. At post-test, 21 intervention and 17 control participants
did not attend the pathology lab for their blood samples orwere exclud-
ed due to a change inmedication from baseline to post-test, resulting in
a ﬁnal sample of 130 (64.7%) intervention and 144 (72.0%) control par-
ticipants for blood analysis.Table 1
Baseline characteristics of participants, Albany Western Australia, 2014–2015.
Variable Intervention group Control group p valuea
(n=151) (n=159)
Age (years) 60.5 (5.64) 61.3 (5.18) 0.18
Gender: female 100 (66.2%) 106 (66.7%) 0.93
Employment status 0.30
Full time 78 (51.7%) 65 (40.9%)
Part time 24 (15.9%) 29 (18.2%)
Unemployed 5 (3.3%) 7 (4.4%)
Retired 44 (29.1%) 58 (36.5%)
Education 0.42
Primary school 3 (2.0%) 2 (1.3%)
Secondary school 55 (36.4%) 72 (45.0%)
TAFE/Diploma 52 (34.4%) 46 (28.8%)
University 41 (27.2%) 39 (24.5%)
Relationship status: with partner 124 (82.1%) 129 (81.1%) 0.81
Smoking status 0.85
Never 84 (55.6%) 84 (52.8%)
Ex-smoker 52 (34.4%) 54 (33.8%)
Occasional smoker 3 (2.0%) 4 (2.5%)
Daily smoker 12 (7.9%) 17 (10.6%)
Co-morbidityb: yes 92 (60.9%) 104 (65.4%) 0.41
Alcohol drinking: yes 99 (65.6%) 113 (71.1%) 0.96
n = 130 n = 144
Metabolic syndrome status 0.66
Metabolic syndrome 66 (50.8%) 77 (46.5%)
At risk 64 (49.2%) 67 (46.5%)
a t-Test or chi square test between intervention and control groups.
b Presence of at least one of 8 common health problems.Table 2 gives the changes in cardiovascular risk factors within and
between intervention and control groups. Signiﬁcant improvements in
triglycerides (−0.1 mM, p = 0.01), total cholesterol(−0.09 mM, p =
0.04), remnant cholesterol (−0.1 mM, p = 0.003), and both systolic
(−5.24 mm Hg, p b 0.001) and diastolic blood pressures
(−2.34 mm Hg, p = 0.002) were observed for the intervention group
from baseline to post-intervention. There were no signiﬁcant within-
group changes in parameters for the control group. The GEE analyses
for cardiovascular risk factors are provided in Table 3. After controlling
for demographic and other potential confounders, signiﬁcant improve-
ments in the intervention group relative to the control group were ob-
served for triglycerides (p = 0.002), total cholesterol (p = 0.02), non-
HDL cholesterol (p = 0.02), and remnant cholesterol (p = 0.03)
through the group x time interaction term.
Table 4 gives the univariate comparisons of anthropometrics be-
tween intervention and control groups. The intervention group signiﬁ-
cantly improved in waist circumference (−2.11 cm, p b 0.001), hip
circumference (−1.25 cm, p b 0.001), waist-to-hip ratio (−0.01, p =
0.002), weight (−0.7 kg, p b 0.001), BMI (−0.2 kg/m2, p b 0.001), and
body fat (−1.5%, p b 0.001) from baseline to post-intervention. Table
5 provides the results from the GEE analyses of anthropometric out-
come measures. Relative to the control group, the intervention group
signiﬁcantly improved in waist circumference (p = 0.03), waist-to-
hip ratio (p = 0.04), weight (p = 0.01), and BMI (p b 0.001) through
the group x time interaction, after controlling for potential confounders.
4. Discussion
There is a high prevalence of poor diet, physical inactivity, and over-
weight/obesity for older adults residing in rural areas of Australia
(Williams et al., 2012). Consequently, the prevalence of metabolic syn-
drome, type 2 diabetes, and chronic disease is higher in these areas
(Australian Institute of Health and Welfare, 2014), highlighting the
need to develop interventions targeting this group (Janus et al., 2007).
This RCT examined the effectiveness of the APAN programme for im-
proving the metabolic syndrome parameters of participants, as a result
of signiﬁcantly improved dietary and physical activity outcomes
(Blackford et al., 2016). The ﬁndings demonstrate that 6-months pro-
gramme engagement in physical activity, nutrition, and weight man-
agement signiﬁcantly improved several metabolic syndrome
parameters and cardiovascular risk factors for the participants. Speciﬁ-
cally, triglycerides, total-, non-HDL- and remnant-cholesterol were all
improved for the intervention group when compared to the control
group, and similar improvementswere evident in anthropometricmea-
surements such as waist circumference, waist-to-hip ratio, weight, and
BMI.
Aerobic exercise and dietary modiﬁcations are considered to be ef-
fective interventions for metabolic syndrome, due to the associated im-
provements in blood pressure, waist circumference, triglycerides, and
HDL cholesterol (Pattyn et al., 2013). Motivational interviewing com-
bined with regular monitoring and feedback are recommended strate-
gies for individuals with metabolic syndrome (Bassi et al., 2014), all of
which hadbeen implemented in the APANprogramme. These strategies
supported behaviour change, resulting in the intervention group mod-
erately increasingmetabolic equivalent (MET) minutes of moderate in-
tensity physical activity per week, signiﬁcantly increasing ﬁbre intake
and vegetable serves per day, and decreasing fat intake when compared
to the control group (Blackford et al., 2016). These reported behaviour
changes impacted on the individual metabolic syndrome parameters
and cardiovascular risk factors.
It is recommended thatweight reduction via dietary and physical ac-
tivity improvements should be the primary intervention goal for indi-
viduals with metabolic syndrome due to the association between
weight loss and lower cholesterol, triglycerides, glucose, and blood
pressure, and increased HDL cholesterol (Blaha et al., 2008; Grundy et
al., 2004). Speciﬁcally, a reduction in abdominal fat, measured by
Table 2
Comparison of changes in metabolic syndrome parameters and cardiovascular risk factors between intervention and control groups, AlbanyWestern Australia, 2014–2015.
Outcome
Intervention group (n = 130)
p valuea
Control group (n = 144)
p valueb p valuec p valued
Baseline Post Baseline Post
Triglycerides (mM)e 1.48 (0.79) 1.36 (0.75) 0.01 1.37 (0.60) 1.47 (0.68) 0.02 0.19 0.09
Glucose (mM) 5.01 (0.46) 5.06 (0.53) 0.19 5.04 (0.49) 5.11 (0.56) 0.07 0.60 0.48
HDL cholesterol (mM) 1.46 (0.42) 1.45 (0.39) 0.44 1.46 (0.42) 1.44 (0.38) 0.45 0.88 0.89
Total cholesterol (mM) 5.56 (0.97) 5.47 (1.02) 0.04 5.40 (1.10) 5.45 (1.03) 0.29 0.19 0.87
LDL cholesterol (mM) 3.42 (0.81) 3.34 (0.95) 0.15 3.32 (0.93) 3.34 (0.90) 0.56 0.31 0.99
Non-HDL cholesterol (mM) 4.10 (0.89) 4.02 (0.96) 0.07 3.94 (1.01) 4.01 (9.33) 0.16 0.17 0.90
Remnant cholesterol (mM)e 0.60 (0.30) 0.50 (0.30) 0.003 0.60 (0.40) 0.60 (0.30) 0.06 0.43 0.05
Systolic blood pressure (mm Hg) 138.54 (14.05) 133.30 (14.85) b0.001 138.56 (14.36) 136.32 (16.10) 0.07 0.99 0.09
Diastolic blood pressure (mm Hg) 87.21 (9.02) 84.87 (9.19) 0.002 85.99 (8.75) 84.96 (9.01) 0.15 0.26 0.95
a Paired t-test between baseline and post-test for the intervention group.
b Paired t-test between baseline and post-test for the control group.
c Independent t-test between intervention and control group at baseline.
d Independent t-test between intervention and control group at re-test.
e Non-parametric tests applied due to skewed distributions.
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and reduced risk of cardiovascular disease (Lemieux et al., 2007). The
signiﬁcant reduction in waist circumference, waist-to-hip ratio, and
blood lipids for the APAN intervention group suggests that the observed
improvements in dietary intake in combinationwith increased physical
activity (Blackford et al., 2016) not only assisted with improved body
composition, but also led to improvements in individual metabolic syn-
drome parameters (Grundy et al., 2004). Abdominal fat mass is sug-
gested to have a direct intermediary role in metabolic syndrome
development (Han & Lean, 2006); therefore the observed reduction in
waist circumference and other measures of body composition for the
APAN intervention groupmay have directly inﬂuenced other metabolic
syndrome parameters.
Individuals at the upper end of the normal BMI range are at a sub-
stantially increased risk of metabolic syndrome; therefore BMI mainte-
nance at 21–22 kg/m2 is recommended for those at risk of, or with
metabolic syndrome (Han & Lean, 2006). A systematic review indicated
that lifestyle interventions resulting in even modest weight loss can ef-
fectively improve blood lipids (Aucott et al., 2011). The intervention
group of the APAN study demonstrated signiﬁcant weight loss relative
to the control group, aswell as a signiﬁcant reduction in BMI. The signif-
icant reduction in triglycerides, total- non-HDL- and remnant cholester-
ol for the APAN intervention group is therefore promising, considering
the important role of blood-lipid regulation via dietary improvements,
increased physical activity, and/or weight loss in prevention and treat-
ment of metabolic syndrome and related chronic diseases (Aucott et
al., 2011).
Even without weight loss, moderate intensity physical activity has
been found to lower triglycerides (Ahmed et al., 2012). The meanTable 3
GEE analysis of metabolic syndrome parameters and cardiovascular risk factors before and afte
Group: intervention T
Coefﬁcient (SE) p⁎ C
Triglycerides (mM)a 0.08 (0.05) 0.14
Glucose (mM)b −0.04 (0.06) 0.54
HDL chol (mM)b 0.04 (0.04) 0.33 −
Total chol (mM)b 0.21 (0.12) 0.07
LDL chol (mM)b 0.12 (0.10) 0.24
Non-HDL chol (mM)b 0.17 (0.11) 0.13
Remnant chol (mM)a 0.10 (0.06) 0.10
Systolic BP (mm Hg)b −0.83 (1.65) 0.62 −
Diastolic BP (mm Hg)b 0.52 (1.02) 0.61 −
a Gamma generalised estimating equation model with log link.
b Normal generalised estimating equation model with identity link.
⁎ Adjusted for age, gender, relationship status, education level, employment status, co-morbmoderate MET minutes per week reported by the APAN intervention
group signiﬁcantly increased from 300 (SD = 585.0) to 480 (SD =
850.0)minutes perweek (p b 0.001) (Blackford et al., 2016),which sug-
gests that improvements in triglycerides may have been observed re-
gardless of weight loss. A systematic review reported signiﬁcant
changes in lipids when moderate intensity activities were performed
for more than 150 minutes per week (Tambalis et al., 2009). The
APAN intervention participants signiﬁcantly reduced their triglycerides,
which is consistent with a meta-analysis of RCTs that examined the ef-
fect of aerobic exercise on lipids (Kelley et al., 2005). The meta-analysis
found that aerobic exercise effectively decreased triglycerides in over-
weight and obese adults (Kelley et al., 2005), which is consistent with
other studies (Lin et al., 2015).
In addition to the beneﬁcial effects on triglycerides, physical activity
can also favourably inﬂuence other lipids. Non-HDL cholesterol includes
all lipids apart from HDL cholesterol, and is considered a more reliable
cardiovascular risk indicator than LDL cholesterol alone (Gordon et al.,
2014). The APAN intervention group signiﬁcantly reduced their non-
HDL cholesterol concentrations relative to the control group, suggesting
that the combination of increased physical activity andweight loss may
have had a beneﬁcial effect on cardiovascular risk. However, previous
meta-analyses have found that non-HDL cholesterol could be signiﬁ-
cantly reduced as a result of aerobic exercise independent of weight
loss (Gordon et al., 2014). Consequently, the reduction among the
APAN participants may have occurred as a result of increased physical
activity alone.
In addition to physical activity, many of themetabolic syndrome and
cardiovascular risk factors are inﬂuenced by the Western diet, and can
be reversed by improvements in dietary intake (Blaha et al., 2008). Ar intervention (n = 274), Albany Western Australia, 2014–2015.
ime: post Grouptime
oefﬁcient (SE) p⁎ Coefﬁcient (SE) p⁎
0.07 (0.03) 0.02 −0.13 (0.04) 0.01
0.06 (0.04) 0.08 −0.01 (0.05) 0.79
0.01 (0.02) 0.47 −0.00 (0.02) 0.93
0.06 (0.05) 0.26 −0.15 (0.07) 0.02
0.02 (0.04) 0.55 −0.11 (0.07) 0.13
0.07 (0.05) 0.14 −0.15 (0.06) 0.02
0.06 (0.03) 0.03 −0.13 (0.06) 0.03
2.19 (1.22) 0.07 −3.09 (1.64) 0.06
0.99 (0.71) 0.17 −1.35 (1.01) 0.18
idity, alcohol drinking, and smoking status.
Table 4
Comparison of changes in anthropometric measurements between intervention and control groups, Albany Western Australia, 2014–2015.
Outcome
Intervention group (n = 151)
p valuea
Control group (n = 161)
p valueb p valuec p valuedd
Baseline Post Baseline Post
Waist circumference (cm) 102.67 (13.58) 100.56 (13.84) b0.001 101.41 (12.93) 100.53 (12.69) 0.02 0.40 0.78
Hip (cm) 112.38 (11.99) 111.13 (12.04) b0.001 111.57 (11.05) 110.57 (10.95) 0.02 0.54 0.67
Waist-to-hip ratio (waist/hip) 0.91 (0.08) 0.90 (0.08) 0.002 0.91 (0.08) 0.91 (0.08) 0.82 0.56 0.58
Weight (kg)d 85.20 (22.60) 84.50 (23.70) b0.001 85.30 (21.90) 86.40 (22.00) 0.12 0.88 0.74
BMI (kg/m2)d 29.55 (6.93) 29.35 (7.00) b0.001 29.80 (7.05) 29.70 (6.90) 0.10 0.88 0.68
Body fat (%)d 40.20 (11.70) 38.70 (11.35) b0.001 38.80 (12.75) 39.10 (12.80) 0.75 0.60 0.77
a Paired t-test between baseline and post-test for the intervention group.
b Paired t-test between baseline and post-test for the control group.
c Independent t-test between intervention and control group at baseline.
d Independent t-test between intervention and control group at re-test.
d Non-parametric tests applied.
20 K. Blackford et al. / Preventive Medicine 89 (2016) 15–22diet rich in fruits, vegetables, and ﬁbre is recommended for individuals
withmetabolic syndrome (Blaha et al., 2008). As such these recommen-
dations were incorporated into the APAN programme strategies. Diets
high in saturated fat are associated with oxidative stress and elevated
LDL and total cholesterol, but not diets high in polyunsaturated fat
(Esposito et al., 2004). Additionally, increased consumption of fruit, veg-
etables, and ﬁbre appear to reduce inﬂammation (Kaur, 2014; Esposito
et al., 2004). Implementation of the APAN programme effectively in-
creased ﬁbre and vegetable intake, and reduced the fat intake among
the intervention group participants (Blackford et al., 2016), which
might have reduced overall oxidative stress. It should be noted that
total- and non-HDL cholesterol were signiﬁcantly lowered for the inter-
vention group.
The improvement of non-HDL cholesterol and triglycerides for the
APAN intervention group suggests that improvements in dietary behav-
iours in combination with marginal improvements in moderate physi-
cal activity and weight loss may have reduced cardiovascular disease
risk for participants. As a predictor of cardiovascular disease, non-HDL
cholesterol is more relevant than LDL cholesterol, particularly in combi-
nation with elevated triglycerides (Blaha et al., 2008). The APAN inter-
vention signiﬁcantly reduced triglycerides and non-HDL cholesterol,
suggesting that it is important to implement changes in both diet and
physical activity to reduce cardiovascular risk.4.1. Strengths and limitations
A major strength of the current study is the recruitment procedure
implemented. There is a paucity of interventions that have used the
IDF criteria to diagnosemetabolic syndrome, which require central obe-
sity to be a characteristic of participants (Higgins & Green, 2011; Lin et
al., 2014). Our use of the IDF deﬁnition enabled the identiﬁcation of in-
dividuals with a large waist circumference and ensured abdominal obe-
sity and related risks were included as outcome measures (Lin et al.,
2014), considering abdominal obesity and insulin resistance are theTable 5
GEE analysis of anthropometric outcomes before and after intervention (n = 312), Albany We
Group: intervention
Coefﬁcient (SE) pc
Waist circumference (cm)a 1.16 (1.33) 0.38
Hip (cm)a 0.66 (1.26) 0.60
Waist-to-hip ratio (waist/hip)a 0.01 (0.01) 0.34
Weight (kg)b 0.01 (0.02) 0.69
BMI (kg/m)b 0.01 (0.02) 0.57
a Normal generalised estimating equation model with identity link.
b Gamma generalised estimating equation model with log link.
c Adjusted for age, gender, relationship status, education level, employment status, co-morbmajor underlying risk factors for metabolic syndrome and its compo-
nents (Grundy et al., 2005). Previous reviews ofmetabolic syndrome tri-
als have highlighted theneed to utilise the current evidence andprovide
up-to-date guidance on the use of the IDF criteria to deﬁne and screen
for metabolic syndrome (Dunkley et al., 2012; Lin et al., 2014). The
IDF criteria is useful in large population groups becausewaist circumfer-
ence as the minimum requirement provides a simple and low-cost
screening process that can be performed at any location (Zimmet et
al., 2005; Dhaliwal et al., 2014).
A limitation of the study was the brief duration of the intervention.
There is a need to develop, evaluate, and disseminate strategies that ef-
fectively promoteweightmaintenance via lifestyle changes (Eakin et al.,
2010). Although 6-month interventions are deemed to be long enough
to reﬂect behaviour change (Stiggelbout et al., 2006), older adults often
require a sufﬁcient dose to ensure behaviour change is maintained,
which can be challenging in the long-term (Burke et al., 2008). Short-
termweight loss programmes are effective in the target group; but par-
ticipants tend to regain weight once such programmes end (Bassi et al.,
2014). Considering the relatively brief duration of the APAN interven-
tion (6-months), it is recommended that longer-term studies are con-
ducted to determine the sustainable effectiveness of similar lifestyle
programmes (Korczak et al., 2011).5. Conclusion
The APAN study has demonstrated the potential beneﬁts of identify-
ing and managing adults aged 50 to 69 years who have or are at risk of
metabolic syndrome in a rural community. The home-based pro-
gramme effectively improved dietary and physical activity behaviours
of participants, which in turn improved individual metabolic syndrome
parameters and cardiovascular risk factors. Comprehensive home-
based prevention programmes that incorporate a combination of die-
tary and physical activity improvements are promising to prevent the
onset of chronic disease in high risk population groups.stern Australia, 2014–2015.
Time: post Group x time
Coefﬁcient (SE) pc Coefﬁcient (SE) pc
−0.87 (0.38) 0.02 −1.17 (0.53) 0.03
−0.98 (0.42) 0.02 −0.26 (0.50) 0.60
0.00 (0.00) 0.82 −0.01 (0.00) 0.04
0.00 (0.00) 0.18 −0.01 (0.00) 0.01
0.00 (0.00) 0.16 −0.01 (0.00) b0.001
idity, alcohol drinking, and smoking status.
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